MedTrace Logo

Prenatal Non-invasive Aneuploidy Test Utilizing SNPs Trial

NCT01545674 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 937

Last updated 2023-03-23

No results posted yet for this study

Summary

This prospective blinded study will assess the diagnostic capability of an informatics enhanced SNP based technology (Parental Support) to identify pregnant women who are carrying a fetus with an aneuploidy from fee floating DNA in the maternal blood.

Conditions

  • Trisomy 13
  • Trisomy 18
  • Trisomy 21
  • Aneuploidy

Interventions

PROCEDURE

Blood Draw

Blood will be drawn from the mother and father

Sponsors & Collaborators

  • Columbia University

    collaborator OTHER

  • George Washington University

    collaborator OTHER

  • Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

    collaborator NIH

  • Natera, Inc.

    lead INDUSTRY

Principal Investigators

  • Ronald Wapner, MD · Columbia University

Eligibility

Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2012-01-31
Primary Completion
2014-04-30
Completion
2023-03-31

Countries

  • United States
  • Canada
  • Ireland
  • Italy
  • South Korea
  • Spain

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01545674 on ClinicalTrials.gov